Does VINORELBINE Cause Second primary malignancy? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Second primary malignancy have been filed in association with VINORELBINE (Vinorelbine). This represents 0.8% of all adverse event reports for VINORELBINE.
39
Reports of Second primary malignancy with VINORELBINE
0.8%
of all VINORELBINE reports
6
Deaths
3
Hospitalizations
How Dangerous Is Second primary malignancy From VINORELBINE?
Of the 39 reports, 6 (15.4%) resulted in death, 3 (7.7%) required hospitalization, and 4 (10.3%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINORELBINE. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does VINORELBINE Cause?
Off label use (644)
Malignant neoplasm progression (624)
Disease progression (526)
Neutropenia (517)
Nausea (504)
Drug ineffective (391)
Fatigue (373)
Diarrhoea (371)
Vomiting (342)
Anaemia (335)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which VINORELBINE Alternatives Have Lower Second primary malignancy Risk?
VINORELBINE vs VINORELBINE\VINORELBINE
VINORELBINE vs VIREAD
VINORELBINE vs VISIPAQUE
VINORELBINE vs VISMODEGIB
VINORELBINE vs VITAMIN A